Tissue Banking Market Share

ID: MRFR/HC/10884-HCR

200 Pages

Rahul Gotadki

October 2025

Tissue Banking Market Research Report By Application (Regenerative Medicine, Drug Discovery, Tissue Engineering, Transplantation), By Type of Tissue Bank (Cell Bank, Organ Bank, Tissue Bank), By Storage Method (Cryopreservation, Lyophilization, Chemical Preservation), By End-use (Hospitals, Research Institutions, Pharmaceutical Companies), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Share

Tissue Banking Market Share Analysis

Around the world, many companies make things like consumer goods, cars, clothes, and electronics. Since there are so many of these companies and they're all competing with each other, they try to use the best and most efficient technologies to make their products cheaper. One way they're doing this is by bringing in something called Industry 4.0 architecture into control valves. This helps them work better and make more things in less time. Industry 4.0 is like a new way of doing things in industries. It includes cool technologies like the Internet of Things (IoT), cloud computing, cyber-physical systems (CPS), digitization, and artificial intelligence (AI). All these things help gather and analyze data and information. When used in control valves, Industry 4.0 makes processes faster and more efficient. This means companies can make high-quality products but at lower costs. The cool part about Industry 4.0 with control valves is that it gives a bunch of benefits. It helps control valves work better, prevents leaks, does things automatically, lets people see what's happening right away, collects and uses data, keeps things safe from cyber threats, and helps predict when valves might need maintenance. When companies use Industry 4.0 with control valves, they can control every part of their work better and get information to make things even better. For example, a company called Bürkert in Germany is focusing on making control valves work with Industry 4.0. They created something called the Efficient Device Integration Platform (EDIP), which connects valves, sensors, and actuators for better operations. Using Industry 4.0 with control valves is a big opportunity for companies in the global control valves market. It lets them make better valves that work precisely and can be used in tricky situations, like monitoring for problems and mixing gases. This not only makes things more efficient but also saves time and money. So, bringing in Industry 4.0 to control valves is a chance for companies to do better and be more successful in the global market.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Tissue Banking Market by 2035?

The Tissue Banking Market is projected to reach a valuation of 8.0 USD Billion by 2035.

What was the market valuation of the Tissue Banking Market in 2024?

In 2024, the Tissue Banking Market was valued at 4.528 USD Billion.

What is the expected CAGR for the Tissue Banking Market from 2025 to 2035?

The expected CAGR for the Tissue Banking Market during the forecast period 2025 - 2035 is 5.31%.

Which application segment is expected to show significant growth in the Tissue Banking Market?

The Regenerative Medicine application segment is anticipated to grow from 1.5 USD Billion in 2024 to 2.5 USD Billion by 2035.

What are the key types of tissue banks in the market?

The key types of tissue banks include Cell Banks, Organ Banks, and Tissue Banks, with Tissue Banks projected to grow from 2.028 USD Billion to 3.7 USD Billion by 2035.

Which storage method is expected to dominate the Tissue Banking Market?

Chemical Preservation is expected to dominate, with a projected growth from 2.028 USD Billion in 2024 to 3.7 USD Billion by 2035.

What are the primary end-use segments for the Tissue Banking Market?

The primary end-use segments include Hospitals, Research Institutions, and Pharmaceutical Companies, with Pharmaceutical Companies expected to grow from 1.828 USD Billion to 3.5 USD Billion by 2035.

Who are the leading players in the Tissue Banking Market?

Key players in the Tissue Banking Market include Tissue Regenix Group, AlloSource, and CryoLife, among others.

How does the Tissue Banking Market's growth compare across different applications?

The Drug Discovery application segment is projected to grow from 1.2 USD Billion in 2024 to 2.0 USD Billion by 2035, indicating robust growth.

What trends are influencing the Tissue Banking Market in 2025?

Trends such as advancements in regenerative medicine and increased demand for organ transplants are influencing the Tissue Banking Market in 2025.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Tissue Banking Market Size was estimated at 4.528 USD Billion in 2024. The Tissue Banking industry is projected to grow from 4.769 USD Billion in 2025 to 8.0 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.31 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Tissue Banking Market is experiencing robust growth driven by technological advancements and increasing demand for regenerative medicine.

Technological advancements are reshaping the landscape of tissue banking, enhancing efficiency and safety. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in tissue banking. The regenerative medicine segment dominates the market, whereas the tissue engineering segment is witnessing rapid growth. Key market drivers include technological innovations in tissue banking and rising applications in regenerative medicine.

Market Size & Forecast

2024 Market Size	4.528 (USD Billion)
2035 Market Size	8.0 (USD Billion)
CAGR (2025 - 2035)	5.31%
Largest Regional Market Share in 2024	North America

Major Players

Tissue Regenix Group (GB), <a href="https://allosource.org/">AlloSource</a> (US), Mediware Information Systems (US), CryoLife (US), Organogenesis (US), Acelity (US), Tissue Bank (AU), Bioventus (US),<a href="https://www.lifenethealth.org/about/divisions/tissue-donation-services"> LifeNet Health</a> (US)

Market Trends

The Tissue Banking Market is currently experiencing a dynamic evolution, driven by advancements in technology and increasing demand for regenerative medicine. The growing awareness of the importance of tissue preservation for research and therapeutic applications appears to be influencing the market landscape significantly. As healthcare systems worldwide continue to prioritize personalized medicine, the need for high-quality biological samples is likely to expand. This trend suggests a shift towards more sophisticated banking solutions that ensure the integrity and viability of stored tissues. Moreover, regulatory frameworks are evolving to accommodate the complexities associated with tissue banking. This development may lead to enhanced standards for quality control and ethical considerations in the collection and storage processes. As a result, stakeholders in the Tissue Banking Market are likely to invest in compliance measures and innovative technologies to meet these emerging requirements. The interplay between technological advancements and regulatory changes indicates a promising future for the market, with potential growth opportunities in various sectors, including pharmaceuticals and biotechnology.

Technological Advancements

The integration of cutting-edge technologies in tissue banking is transforming the landscape. Innovations such as automated storage systems and advanced cryopreservation techniques are enhancing the efficiency and reliability of tissue preservation. This trend may lead to improved sample quality and accessibility for research and clinical applications.

Regulatory Developments

The evolving regulatory environment surrounding tissue banking is shaping operational practices. Stricter guidelines and standards are being established to ensure ethical collection and storage of biological materials. This trend suggests that organizations may need to adapt their processes to comply with new regulations, potentially impacting market dynamics.

Increased Demand for Regenerative Medicine

The rising interest in regenerative medicine is driving the need for high-quality tissue samples. As therapies utilizing stem cells and other biological materials gain traction, the Tissue Banking Market is likely to see a surge in demand. This trend indicates a growing recognition of the value of preserved tissues in advancing medical research and treatment.

Tissue Banking Market Market Drivers

Regulatory Support and Frameworks

The Tissue Banking Market is bolstered by evolving regulatory support and frameworks that aim to ensure the safety and quality of tissue products. Regulatory bodies are establishing guidelines that facilitate the ethical collection, processing, and distribution of tissues. These regulations are designed to protect both donors and recipients, thereby enhancing public trust in tissue banking practices. As compliance with these regulations becomes more streamlined, tissue banks may find it easier to operate and expand their services. This supportive regulatory environment is likely to contribute positively to the growth trajectory of the Tissue Banking Market.

Growing Awareness of Tissue Donation

The Tissue Banking Market is benefiting from a growing awareness of the importance of tissue donation among the public. Educational campaigns and outreach programs are increasingly highlighting the life-saving potential of donated tissues, which is likely to enhance donor participation rates. As more individuals recognize the impact of their contributions, the supply of tissues available for banking is expected to increase. This heightened awareness not only supports the operational capacity of tissue banks but also fosters a culture of donation that is essential for the sustainability of the Tissue Banking Market.

Increased Focus on Personalized Medicine

The Tissue Banking Market is increasingly influenced by the shift towards personalized medicine, which emphasizes tailored treatment approaches based on individual patient profiles. This trend necessitates the availability of diverse tissue samples that can be matched to specific genetic and phenotypic characteristics. As healthcare providers and researchers strive to develop personalized therapies, the demand for biobanks that can provide a wide array of tissues is expected to rise. This focus on personalized medicine may lead to a more robust Tissue Banking Market, as institutions invest in expanding their tissue collections to support research and clinical applications.

Technological Innovations in Tissue Banking

The Tissue Banking Market is experiencing a surge in technological innovations that enhance the efficiency and effectiveness of tissue preservation and storage. Advanced cryopreservation techniques, for instance, are being developed to improve the viability of stored tissues. Moreover, automation in tissue processing and storage systems is streamlining operations, reducing human error, and increasing throughput. The integration of artificial intelligence in tissue banking is also emerging, allowing for better inventory management and predictive analytics. As a result, these technological advancements are likely to attract more investments and drive growth in the Tissue Banking Market, with projections indicating a compound annual growth rate of over 10% in the coming years.

Rising Applications in Regenerative Medicine

The Tissue Banking Market is witnessing a notable increase in applications within the field of regenerative medicine. As the demand for innovative therapies rises, the need for high-quality tissue samples becomes paramount. Regenerative medicine relies heavily on tissues for research and therapeutic purposes, including stem cell therapy and tissue engineering. The market for regenerative medicine is projected to reach USD 100 billion by 2025, which underscores the critical role of tissue banks in supplying the necessary biological materials. This growing intersection between tissue banking and regenerative medicine is likely to propel the Tissue Banking Market forward, as stakeholders seek to meet the escalating demand for viable tissues.

Market Segment Insights

By Application: Regenerative Medicine (Largest) vs. Tissue Engineering (Fastest-Growing)

In the Tissue Banking Market, the application segment is dominated by regenerative medicine, which holds the largest market share. This segment promises significant advancements in healing and recovery processes through tissue transplants and cellular therapies. Following closely is the field of transplantation, reflecting a vital application of tissue banking for organ and cellular grafts. Emerging segments like drug discovery and tissue engineering are making noteworthy inroads, driven by innovative applications and heightened research activities in laboratory settings.

Regenerative Medicine (Dominant) vs. Tissue Engineering (Emerging)

Regenerative medicine is a dominant player in the tissue banking market, focusing on restoring or replacing damaged tissues through the use of cells, tissues, or organ grafts. This segment leverages advancements in biotechnology and stem cell research to offer solutions for complex medical conditions. Meanwhile, tissue engineering is identified as the fastest-growing segment, combining biological and engineering principles to develop biological substitutes that restore, maintain, or improve tissue functions. This emerging segment is benefiting from increasing research funding, technological innovations, and collaborations between academic and industry players that illustrate its vital role in future healthcare solutions.

By Type of Tissue Bank: Cell Bank (Largest) vs. Organ Bank (Fastest-Growing)

The Tissue Banking Market showcases a diverse landscape, primarily categorized into Cell Banks, Organ Banks, and Tissue Banks. Among these, Cell Banks hold the largest market share due to their extensive applications in regenerative medicine, cell therapy, and research. Meanwhile, Organ Banks are gaining traction, particularly in the context of increased organ transplantation initiatives and growing awareness of organ donation among the public. This evolving market dynamic is indicative of the changing landscape in healthcare, where tissue banking plays a pivotal role in the advancement of medical science.

Cell Bank (Dominant) vs. Organ Bank (Emerging)

Cell Banks are well-established entities in the Tissue Banking Market, primarily focusing on the procurement, preservation, and distribution of various cell types for therapeutic applications. These banks have vast networks and protocols in place that ensure high-quality cell storage and compliance with regulatory standards. On the other hand, Organ Banks, while emerging, are rapidly expanding due to the increasing demand for organ transplants fueled by advancements in surgical techniques and improved outcomes. They prioritize the ethical sourcing of organs and post-operative care, making them indispensable as public health initiatives evolve. While Cell Banks dominate market share with their robust foundation, Organ Banks are poised for notable growth, showcasing a shift in focus toward organ preservation and transplantation.

By Storage Method: Cryopreservation (Largest) vs. Lyophilization (Fastest-Growing)

In the Tissue Banking Market, the storage method segment is predominantly led by cryopreservation, which has established itself as the largest method due to its effectiveness in maintaining the viability of cells, tissues, and organs over extended periods. This method accounts for a considerable share in the segment, as hospitals and research institutions increasingly prefer it for tissue preservation. Lyophilization is emerging rapidly, capturing attention due to its ability to offer long-term stability and convenient transportation, making it particularly appealing for certain tissue types.

Storage Method: Cryopreservation (Dominant) vs. Lyophilization (Emerging)

Cryopreservation remains the dominant storage method in the Tissue Banking Market, favored for its proficiency in preserving living cells and biological materials at low temperatures, effectively halting metabolic and degradative processes. This method is crucial for long-term storage of various tissues including stem cells and gametes. In contrast, lyophilization is gaining traction as an emerging method due to its ability to preserve biological activity while simplifying storage logistics. It does not require extreme refrigeration, making it suitable for sectors looking for stable and transport-friendly solutions. As biobanking continues to evolve, these methods will likely present unique benefits catering to specific preservation needs.

By End-use: Hospitals (Largest) vs. Research Institutions (Fastest-Growing)

In the Tissue Banking Market, hospitals account for the largest share of the end-use segment due to their essential roles in surgical procedures, diagnostics, and patient care. They establish significant tissue banks to support organ transplants and regenerative medicine. Research institutions follow as a rapidly growing segment, focusing on innovative research and development of new therapies, which is increasingly driving tissue procurement and usage. Their demand for more varied and specialized tissue types is transforming the market landscape.

Hospitals (Dominant) vs. Research Institutions (Emerging)

Hospitals are the dominant end-users in the Tissue Banking Market, primarily due to their established infrastructure for tissue procurement and storage. They maintain large tissue banks to support transplant services and other medical treatments that require human tissue. On the other hand, research institutions represent the emerging segment, driving innovation in tissue utilization for experimental therapies and <a href="https://www.marketresearchfuture.com/reports/clinical-trials-market-7787">clinical trials</a>. Their rapid growth is fueled by the increasing emphasis on personalized medicine and regenerative therapies, which require diverse tissue samples. The interplay between these two segments is crucial as hospitals continue to enable research institutions with the necessary biological materials for advancement in medical science.

Get more detailed insights about Tissue Banking Market Research Report—Global Forecast till 2035

Regional Insights

The Tissue Banking Market comprised various regions, each contributing to its overall growth. In 2024, North America led the charge at 1.75 USD Billion, which showcases its majority holding in this market segment.

Europe followed with a valuation of 1.30 USD Billion, reflecting its significant presence. The Asia Pacific region is expected to reach 0.95 USD Billion, indicating a growing adoption of tissue banking technologies.

South America, while smaller, attained 0.30 USD Billion, showing potential for growth, while the Middle East and Africa had a value of 0.23 USD Billion, indicating their emerging role in the tissue banking landscape.

The trends within these regions reflected the growing demand for advanced medical research applications and the increasing prevalence of chronic diseases, making tissue banks critical for research and development.

North America’s dominance was supported by a robust healthcare system and significant investment in Research and Development, while Europe benefited from stringent regulatory frameworks promoting tissue preservation integrity. Overall, the market's growth is driven by technological advancements, increased awareness, and potential applications across various medical fields.

Tissue Banking Market Regional Insights

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Tissue Banking Market is a dynamic and rapidly evolving sector, characterized by a variety of players that contribute to the growth and sustainability of biobanks. With advancements in biopreservation techniques, regulatory frameworks, and technological innovations, the competitive landscape is shaped by a blend of established companies and emerging entrants.

As the demand for biological samples grows across research, diagnostics, and therapeutic development, companies are increasingly focusing on enhancing their product offerings, improving operational efficiency, and expanding their geographic reach to capture market share.

Strategic collaborations, partnerships, and mergers are becoming common as firms aim to optimize their capabilities and broaden their service portfolio in response to the escalating needs of the healthcare and biotechnology industries.

Thermo Fisher Scientific stands out in the Tissue Banking Market with its strong focus on biobanking solutions that support clinical research, personalized medicine, and regenerative therapies.

The company's extensive range of products, which includes bioprocessing equipment, storage systems, and molecular biology tools, enhances its ability to meet diverse client needs across different applications.

Thermo Fisher Scientific operates on a global scale, leveraging its extensive distribution network to facilitate accessibility to its innovative technologies in various regions. The company's strengths lie in its commitment to quality and innovation, evidenced by its investment in R&D and its capacity to deliver high-quality products that comply with international standards.

This positions Thermo Fisher Scientific as a frontrunner in the market, enabling it to maintain a solid competitive advantage while addressing emerging challenges in tissue banking.

BioLife Sciences is another significant player in the Tissue Banking Market, known for its sophisticated biopreservation solutions and sample management systems that cater to the needs of researchers and clinicians worldwide.

The company offers a wide array of key products and services, including controlled-rate freezers, temperature monitoring systems, and storage solutions that ensure sample integrity over extended periods.

BioLife Sciences is recognized for its strong market presence, owing to its strategic focus on innovation and customer collaboration. Its strengths include a dedicated approach to quality assurance and the ability to respond swiftly to market demands.

Furthermore, BioLife Sciences has established partnerships and collaborations that bolster its offerings, alongside recent mergers and acquisitions aimed at expanding its technological capabilities and enhancing its global footprint within the tissue banking sector.

This strategic positioning enhances BioLife Sciences’ competitive edge, enabling it to foster growth and respond to the dynamic landscape of the Tissue Banking Market effectively.

Key Companies in the Tissue Banking Market market include

Industry Developments

Through its LongevityBank subsidiary, CytoMed Therapeutics strengthened its strategy in cord blood-derived biologics in October 2024 by completing the acquisition of a Malaysian cord blood banking license and assets, including cryopreservation equipment, more than 12,000 cord blood units, and real estate facilities.

The same month, BioTissue and LifeLink Tissue Bank established a strategic partnership in which BioTissue transforms placental tissue recovered by LifeLink into surgical and ophthalmic treatments, increasing the use of birth tissue and raising the bar for moral, high-quality transplantation.

By selling two BioArchive cryogenic systems to HealthBanks Biotech Company Ltd. in August 2023, ThermoGenesis increased its market presence in Asia and boosted its storage capacity to 60,000 stem cell units in Taiwan, Hong Kong, Thailand, and the United States. ThermoGenesis also strengthened its position in the market by integrating AXP and BioArchive systems.

In order to move the technology from engineering spec to industrial-scale manufacturing and support late-phase clinical trials in severe burns throughout Europe and Switzerland, Swiss biotech CUTISS teamed up with Tecan on April 14, 2025, to advance automation for the production of denovoSkin, a customized, bilayer human skin graft.

Last but not least, Japan Tissue Engineering Co., Ltd. (J-TEC) achieved a major regulatory milestone in regenerative tissue therapies on May 13, 2025, when it was granted enhanced approval for its autologous cultured cartilage product JACC to treat osteoarthritis.

Future Outlook

Tissue Banking Market Future Outlook

The Tissue Banking Market is projected to grow at a 5.31% CAGR from 2024 to 2035, driven by advancements in regenerative medicine, increasing demand for organ transplants, and technological innovations.

New opportunities lie in:

Expansion of biobanking services for <a href="https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937">personalized medicine</a>Development of automated tissue processing systemsStrategic partnerships with healthcare providers for tissue sourcing

By 2035, the Tissue Banking Market is expected to be robust, driven by innovation and strategic collaborations.

Market Segmentation

Tissue Banking Market End-use Outlook

Hospitals
Research Institutions
Pharmaceutical Companies

Tissue Banking Market Application Outlook

Regenerative Medicine
Drug Discovery
Tissue Engineering
Transplantation

Tissue Banking Market Storage Method Outlook

Cryopreservation
Lyophilization
Chemical Preservation

Tissue Banking Market Type of Tissue Bank Outlook

Cell Bank
Organ Bank
Tissue Bank

Report Scope

MARKET SIZE 2024	4.528(USD Billion)
MARKET SIZE 2025	4.769(USD Billion)
MARKET SIZE 2035	8.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.31% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Advancements in regenerative medicine drive demand for innovative solutions in the Tissue Banking Market.
Key Market Dynamics	Rising demand for regenerative medicine drives innovation and competition in the tissue banking sector.
Countries Covered	North America, Europe, APAC, South America, MEA